DermTech, Inc.·4

Sep 12, 8:06 PM ET

Ibarra Claudia 4

4 · DermTech, Inc. · Filed Sep 12, 2023

Insider Transaction Report

Form 4
Period: 2023-09-08
Ibarra Claudia
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2023-09-08$1.93/sh2,126$4,103205,802 total
  • Sale

    Common Stock

    2023-09-11$1.89/sh322$609200,396 total
  • Sale

    Common Stock

    2023-09-08$1.93/sh2,405$4,642203,397 total
  • Sale

    Common Stock

    2023-09-08$1.93/sh2,679$5,170200,718 total
  • Sale

    Common Stock

    2023-09-08$1.93/sh168$324207,928 total
Footnotes (5)
  • [F1]The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 29, 2021.
  • [F2]The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 23, 2022.
  • [F3]The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 7, 2023.
  • [F4]The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on January 17, 2020.
  • [F5]The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on June 24, 2020.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION